These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 32387864)

  • 1. SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects.
    Michalakis K; Ilias I
    Diabetes Metab Syndr; 2020; 14(4):469-471. PubMed ID: 32387864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity.
    Pasquarelli-do-Nascimento G; Braz-de-Melo HA; Faria SS; Santos IO; Kobinger GP; Magalhães KG
    Front Endocrinol (Lausanne); 2020; 11():530. PubMed ID: 32849309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 and obesity: links and risks.
    Lavie CJ; Sanchis-Gomar F; Henry BM; Lippi G
    Expert Rev Endocrinol Metab; 2020 Jul; 15(4):215-216. PubMed ID: 32441223
    [No Abstract]   [Full Text] [Related]  

  • 4. [Obesity as a risk factor in COVID-19: Possible mechanisms and implications].
    Petrova D; Salamanca-Fernández E; Rodríguez Barranco M; Navarro Pérez P; Jiménez Moleón JJ; Sánchez MJ
    Aten Primaria; 2020; 52(7):496-500. PubMed ID: 32586628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and COVID-19: The clash of two pandemics.
    Chua MWJ; Zheng S
    Obes Res Clin Pract; 2020; 14(4):380-382. PubMed ID: 32631805
    [No Abstract]   [Full Text] [Related]  

  • 6. Endocrine and metabolic link to coronavirus infection.
    Bornstein SR; Dalan R; Hopkins D; Mingrone G; Boehm BO
    Nat Rev Endocrinol; 2020 Jun; 16(6):297-298. PubMed ID: 32242089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Influenza Virus to Novel Corona Virus (SARS-CoV-2)-The Contribution of Obesity.
    Bhattacharya I; Ghayor C; Pérez Dominguez A; Weber FE
    Front Endocrinol (Lausanne); 2020; 11():556962. PubMed ID: 33123087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 Pandemic: Hopes from Proteomics and Multiomics Research.
    Ray S; Srivastava S
    OMICS; 2020 Aug; 24(8):457-459. PubMed ID: 32427517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity Is a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms.
    Sattar N; McInnes IB; McMurray JJV
    Circulation; 2020 Jul; 142(1):4-6. PubMed ID: 32320270
    [No Abstract]   [Full Text] [Related]  

  • 10. Stabilizing Cellular Barriers: Raising the Shields Against COVID-19.
    Hanchard J; Capó-Vélez CM; Deusch K; Lidington D; Bolz SS
    Front Endocrinol (Lausanne); 2020; 11():583006. PubMed ID: 33101215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 and the possible connection to ERs, ACE2, and RAGE: Focus on susceptibility factors.
    Stilhano RS; Costa AJ; Nishino MS; Shams S; Bartolomeo CS; Breithaupt-Faloppa AC; Silva EA; Ramirez AL; Prado CM; Ureshino RP
    FASEB J; 2020 Nov; 34(11):14103-14119. PubMed ID: 32965736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose-6-Phosphate Dehydrogenase Deficiency and COVID-19 Infection.
    Vick DJ
    Mayo Clin Proc; 2020 Aug; 95(8):1803-1804. PubMed ID: 32680625
    [No Abstract]   [Full Text] [Related]  

  • 13. Obesity and impaired metabolic health in patients with COVID-19.
    Stefan N; Birkenfeld AL; Schulze MB; Ludwig DS
    Nat Rev Endocrinol; 2020 Jul; 16(7):341-342. PubMed ID: 32327737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Will the COVID-19 pandemic worsen the obesity epidemic?
    Clemmensen C; Petersen MB; Sørensen TIA
    Nat Rev Endocrinol; 2020 Sep; 16(9):469-470. PubMed ID: 32641837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of SARS-CoV-2 infection and clinical outcomes in multiple sclerosis patients in La Rioja (Spain).
    Castillo Álvarez F; López Pérez MÁ; Marzo Sola ME
    Med Clin (Barc); 2020 Oct; 155(8):362-363. PubMed ID: 32718720
    [No Abstract]   [Full Text] [Related]  

  • 16. Obesity and COVID-19.
    Azzolino D; Cesari M
    Front Endocrinol (Lausanne); 2020; 11():581356. PubMed ID: 33101213
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19: a conundrum to decipher.
    Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review.
    Montalvan V; Lee J; Bueso T; De Toledo J; Rivas K
    Clin Neurol Neurosurg; 2020 Jul; 194():105921. PubMed ID: 32422545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The endocrine and metabolic link between COVID-19, diabetes and obesity].
    Weis N; Thorsteinsson K; Martinussen C; Madsbad S
    Ugeskr Laeger; 2020 Jul; 182(29):. PubMed ID: 32734864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE2 receptor expression in testes: implications in coronavirus disease 2019 pathogenesis†.
    Verma S; Saksena S; Sadri-Ardekani H
    Biol Reprod; 2020 Aug; 103(3):449-451. PubMed ID: 32427288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.